Karl Arne Krister Borrebaeck

Karl Arne Krister Borrebaeck

Founder presso SENZAGEN AB

76 anni
Health Technology
Commercial Services
Finance

Profilo

Karl Arne Krister Borrebaeck is the founder of BioInvent International AB (founded in 1997), Alligator Bioscience AB (founded in 2001), Immunovia AB (founded in 2007), and SenzaGen AB (founded in 2010).
He holds the title of Director at BioInvent International AB from 2010 to 2012, Non-Independent Director at Alligator Bioscience AB from 2001 to 2021, Independent Chairman at Immunovia AB from 2013 to 2023, and previously served as Chairman at SenzaGen AB.
Dr. Borrebaeck's current jobs include Chairman at PainDrainer AB, Director at Royal Swedish Academy of Engineering Sciences, Program Director & Professor-Immunotechnology at Create Health, Director at CB Ocean Capital AB, Director at Ocean Capital AB, and Partner at Immunova Handelsbolag.
Dr. Borrebaeck's former jobs include Chairman at Lund University Bioscience AB, Chairman at Forskarpatent i Syd AB, Director at Eurocine Vaccines AB, Deputy Director at Wihlborgs Ideon.
Fastigheter AB, Director at Nordic Vaccine A, Director at LU Holding AB, Director at Clinical Laserthermia Systems AB, Director at Wntresearch AB, Director at NordicBioscience AB, Director at Qlucore AB, Deputy Director at Endo Medical AB, Deputy Director at Kvinnohalsan - Gyn Art AB, Director at Medicon Village AB, Director at Atlas Therapeutics AB, Director at Ideon Center AB, Director at Scandion Oncology A, and Vice President & Professor at the University of Lund.
Dr. Borrebaeck's education includes undergraduate and doctorate degrees from the University of Lund.

Posizioni attive di Karl Arne Krister Borrebaeck

SocietàPosizioneInizio
SENZAGEN AB Founder 18/08/2010
Immunova Handelsbolag Corporate Officer/Principal -
Ocean Capital AB Director/Board Member -
CB Ocean Capital AB Director/Board Member -
Director/Board Member 29/06/2009
Create Health Corporate Officer/Principal -
Chairman -
Tutte le posizioni attive di Karl Arne Krister Borrebaeck

Precedenti posizioni note di Karl Arne Krister Borrebaeck

SocietàPosizioneFine
IMMUNOVIA AB Founder 26/05/2023
ALLIGATOR BIOSCIENCE AB Founder 01/06/2021
░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Vedi nel dettaglio l'esperienza di Karl Arne Krister Borrebaeck

Formazione di Karl Arne Krister Borrebaeck

University of Lund Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Karl Arne Krister Borrebaeck

Relazioni

100 +

Relazioni di 1° grado

27

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa9
EUROCINE VACCINES AB

Health Technology

BIOINVENT INTERNATIONAL AB

Health Technology

ALLIGATOR BIOSCIENCE AB

Health Technology

CLINICAL LASERTHERMIA SYSTEMS AB

Health Technology

IMMUNOVIA AB

Health Technology

WNTRESEARCH AB

Health Technology

QLUCORE AB

Technology Services

SENZAGEN AB

Health Technology

SCANDION ONCOLOGY A/S

Health Technology

Aziende private17

Finance

Commercial Services

Health Technology

Finance

Finance

Create Health

NordicBioscience AB

Commercial Services

Endo Medical AB

Kvinnohalsan - Gyn Art AB

Commercial Services

Health Technology

CB Ocean Capital AB

Ocean Capital AB

Immunova Handelsbolag

Commercial Services

Technology Services

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Karl Arne Krister Borrebaeck